Engineered Plant PDC Biosynthesis from Protocatechuate
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is no reported chemical synthesis of 2-pyrone-4,6-dicarboxylic acid (PDC), and plants have not been utilized as a platform for its production, despite its potential as a building block for performance-advantaged polymers and biobased applications.
Innovation Solution
Genetically modified plants or plant cells are engineered to express heterologous enzymes such as protocatechuate 4,5-dioxygenase and 4-carboxy-2-hydroxymuconate-6-semialdehyde dehydrogenase, integrated with specific promoters, to biosynthesize PDC from protocatechuate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis methods are used for PDC production, then manufacturing speed and scalability would improve, but no chemical synthesis route has been established yet making this approach unavailable
Solution Approach 1:
The patent uses engineered microbial cells as intermediary factories to convert protocatechuate into PDC through introduced enzymatic pathways. The microbial host serves as a mediator that bridges the gap between available biochemical pathways and the desired PDC product, enabling production without requiring direct chemical synthesis development.
Solution Approach 2:
The engineered microbial system performs self-service by autonomously carrying out the multi-step conversion of protocatechuate to PDC through expressed enzymatic pathways. The biological system automatically manages the complex biochemical transformations without requiring external chemical synthesis interventions.
2Productivity
If engineered microbial hosts are used for PDC production, then production capability is achieved, but the cost and complexity of microbial engineering and fermentation increases
Solution Approach 1:
The patent employs universally applicable microbial hosts (E. coli, P. putida, N. aromaticivorans) that can perform multiple functions: serving as the chassis for pathway introduction, providing native metabolic capabilities for precursor supply, and enabling scalable fermentation production. This multi-functionality reduces the need for specialized engineering solutions.
Solution Approach 2:
The patent optimizes key parameters including introducing feedback-resistant variants of pathway enzymes (e.g., AroG with L175Q mutation) to overcome regulatory limitations, adjusting expression levels of introduced genes, and modifying cultural conditions to maximize PDC yield while managing engineering complexity.
3Ease of manufacture
If plants are used as a production platform for PDC, then cost-effectiveness and sustainability improve, but this approach has not been previously demonstrated requiring de novo pathway implementation
Solution Approach 1:
The patent segments the PDC biosynthetic pathway into discrete enzymatic steps that can be independently introduced and optimized in the plant system. The pathway is divided into: (1) protocatechuate formation from shikimate pathway intermediates, (2) oxidative ring cleavage by PmdAB, and (3) PDC formation by PmdC, allowing modular engineering and troubleshooting.
Solution Approach 2:
The patent ensures preliminary availability of protocatechuate precursors through integration with the plant's native shikimate pathway, which naturally produces the necessary intermediates. This preliminary action of having precursors readily available simplifies the overall engineering task by focusing only on the novel PDC-specific enzymatic steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables cost-effective production of PDC in plants, offering advantages in manufacturing novel polymers and biopolymers with enhanced properties, and potential applications in agriculture, biomedicine, and decontamination.
Implementation Method 1
engineered to express heterologous enzymes such as protocatechuate 4,5-dioxygenase and 4-carboxy-2-hydroxymuconate-6-semialdehyde dehydrogenase, integrated with specific promoters, to biosynthesize PDC from protocatechuate
Data Source
AI summary
The present invention provides a genetically modified plant or plant cell comprising a nucleic acid encoding one or more heterologous enzymes operably linked a promoter, wherein one or more heterologous enzymes synthesizes 2-pyrone-4,6-dicarboxylic acid (PDC).